opens in a new window
NEWS & MEDIA
Lipid Based Drug Delivery Webinar
Mike Frodsham, Chief Technical Officer and Alison Foster, Head of Technical for Pre-Clinical Service, recently held a webinar…
Quay Receives Funding For Covid-19 Treatment Project
Quay Pharma has been awarded Innovate Funding from the Welsh Government for a significant anti-viricidal project as part of…
Meet our CTO Mike Frodsham
Meet our Chief Technical Officer (CTO), Mike Frodsham. Mike discusses his role and Quay Pharma. Watch him in our latest ‘Meet the Team’ film.
Quay Expands with Second UK Facility
Quay Pharma is further expanding its operations with the purchase of a second UK laboratory and office facility. Located at Newtech Square…
Introduction to Quay Pharma
A brief introduction to Quay Pharma that was recently created for one of the many virtual conferences that Quay Pharma has been attending.
Partnership Accelerates Drug Development
We are strengthening our range of pre-clinical services with the establishment of a new partnership with XenoGesis, the UK’s largest independent…
Quay Pharmaceuticals Expands in America
Quay Pharma has underlined its position as a major player in the global pharmaceutical contract development and manufacturing (CDMO) sector with the creation…
Lipophilic Drug Delivery Systems Case Study
Listen to Professor Mike Rubinstein, Chairman, and Co-Founder of Quay Pharma talk about a case study on Lipophilic Drug Delivery Systems.
New Drug for TACTIC-E COVID-19 Trial
Pharmaceutical outsourcing specialist Quay Pharma’s acknowledged expertise in microbial biotherapeutics has played a crucial role…
INSPECTED FACILITIES
